nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—TOP2A—salivary gland cancer	0.235	1	CbGaD
Doxorubicin—thyroid cancer—salivary gland cancer	0.195	0.289	CtDrD
Doxorubicin—bone cancer—salivary gland cancer	0.144	0.214	CtDrD
Doxorubicin—muscle cancer—salivary gland cancer	0.128	0.189	CtDrD
Doxorubicin—peripheral nervous system neoplasm—salivary gland cancer	0.106	0.157	CtDrD
Doxorubicin—sarcoma—salivary gland cancer	0.102	0.151	CtDrD
Doxorubicin—ABCB8—tongue—salivary gland cancer	0.00325	0.0804	CbGeAlD
Doxorubicin—Valrubicin—TOP2A—salivary gland cancer	0.00157	0.431	CrCbGaD
Doxorubicin—CBR3—parotid gland—salivary gland cancer	0.00147	0.0362	CbGeAlD
Doxorubicin—CBR3—saliva-secreting gland—salivary gland cancer	0.0014	0.0347	CbGeAlD
Doxorubicin—AKR1A1—parotid gland—salivary gland cancer	0.00113	0.028	CbGeAlD
Doxorubicin—AKR1A1—saliva-secreting gland—salivary gland cancer	0.00108	0.0268	CbGeAlD
Doxorubicin—NDUFS7—connective tissue—salivary gland cancer	0.000905	0.0224	CbGeAlD
Doxorubicin—Idarubicin—TOP2A—salivary gland cancer	0.000904	0.248	CrCbGaD
Doxorubicin—NDUFS2—parotid gland—salivary gland cancer	0.000852	0.0211	CbGeAlD
Doxorubicin—NDUFS3—parotid gland—salivary gland cancer	0.000842	0.0208	CbGeAlD
Doxorubicin—NDUFS2—saliva-secreting gland—salivary gland cancer	0.000816	0.0202	CbGeAlD
Doxorubicin—NDUFS3—saliva-secreting gland—salivary gland cancer	0.000806	0.0199	CbGeAlD
Doxorubicin—NOS3—neck—salivary gland cancer	0.0008	0.0198	CbGeAlD
Doxorubicin—DHCR7—parotid gland—salivary gland cancer	0.0008	0.0198	CbGeAlD
Doxorubicin—DHCR7—saliva-secreting gland—salivary gland cancer	0.000766	0.0189	CbGeAlD
Doxorubicin—NDUFS2—connective tissue—salivary gland cancer	0.00075	0.0185	CbGeAlD
Doxorubicin—NDUFS3—connective tissue—salivary gland cancer	0.000741	0.0183	CbGeAlD
Doxorubicin—YWHAG—parotid gland—salivary gland cancer	0.000734	0.0181	CbGeAlD
Doxorubicin—AKR1A1—lymphoid tissue—salivary gland cancer	0.000728	0.018	CbGeAlD
Doxorubicin—NOS1—epithelium—salivary gland cancer	0.000716	0.0177	CbGeAlD
Doxorubicin—YWHAG—saliva-secreting gland—salivary gland cancer	0.000703	0.0174	CbGeAlD
Doxorubicin—ABCC6—connective tissue—salivary gland cancer	0.000686	0.017	CbGeAlD
Doxorubicin—Epirubicin—TOP2A—salivary gland cancer	0.000685	0.188	CrCbGaD
Doxorubicin—RALBP1—parotid gland—salivary gland cancer	0.000663	0.0164	CbGeAlD
Doxorubicin—YWHAG—connective tissue—salivary gland cancer	0.000646	0.016	CbGeAlD
Doxorubicin—RALBP1—saliva-secreting gland—salivary gland cancer	0.000635	0.0157	CbGeAlD
Doxorubicin—CBR1—parotid gland—salivary gland cancer	0.000619	0.0153	CbGeAlD
Doxorubicin—AURKA—lymphoid tissue—salivary gland cancer	0.000615	0.0152	CbGeAlD
Doxorubicin—AKR1C3—parotid gland—salivary gland cancer	0.000611	0.0151	CbGeAlD
Doxorubicin—NQO1—neck—salivary gland cancer	0.000609	0.015	CbGeAlD
Doxorubicin—CBR1—saliva-secreting gland—salivary gland cancer	0.000593	0.0146	CbGeAlD
Doxorubicin—NOS3—connective tissue—salivary gland cancer	0.000574	0.0142	CbGeAlD
Doxorubicin—POR—parotid gland—salivary gland cancer	0.000558	0.0138	CbGeAlD
Doxorubicin—ABCB8—lymph node—salivary gland cancer	0.000553	0.0137	CbGeAlD
Doxorubicin—NDUFS2—lymphoid tissue—salivary gland cancer	0.000548	0.0136	CbGeAlD
Doxorubicin—NOS3—epithelium—salivary gland cancer	0.000545	0.0135	CbGeAlD
Doxorubicin—NDUFS3—lymphoid tissue—salivary gland cancer	0.000542	0.0134	CbGeAlD
Doxorubicin—POR—saliva-secreting gland—salivary gland cancer	0.000534	0.0132	CbGeAlD
Doxorubicin—CBR3—lymph node—salivary gland cancer	0.000532	0.0132	CbGeAlD
Doxorubicin—DHCR7—lymphoid tissue—salivary gland cancer	0.000515	0.0127	CbGeAlD
Doxorubicin—NQO1—parotid gland—salivary gland cancer	0.000496	0.0123	CbGeAlD
Doxorubicin—Daunorubicin—TOP2A—salivary gland cancer	0.000485	0.133	CrCbGaD
Doxorubicin—NQO1—saliva-secreting gland—salivary gland cancer	0.000475	0.0117	CbGeAlD
Doxorubicin—YWHAG—lymphoid tissue—salivary gland cancer	0.000472	0.0117	CbGeAlD
Doxorubicin—ABCC10—parotid gland—salivary gland cancer	0.000443	0.0109	CbGeAlD
Doxorubicin—NQO1—connective tissue—salivary gland cancer	0.000436	0.0108	CbGeAlD
Doxorubicin—ABCC10—saliva-secreting gland—salivary gland cancer	0.000424	0.0105	CbGeAlD
Doxorubicin—NOS3—lymphoid tissue—salivary gland cancer	0.00042	0.0104	CbGeAlD
Doxorubicin—NQO1—epithelium—salivary gland cancer	0.000414	0.0102	CbGeAlD
Doxorubicin—AKR1A1—lymph node—salivary gland cancer	0.000411	0.0102	CbGeAlD
Doxorubicin—CBR1—lymphoid tissue—salivary gland cancer	0.000398	0.00984	CbGeAlD
Doxorubicin—NDUFS7—lymph node—salivary gland cancer	0.000373	0.00923	CbGeAlD
Doxorubicin—AURKA—lymph node—salivary gland cancer	0.000347	0.00858	CbGeAlD
Doxorubicin—ABCC1—parotid gland—salivary gland cancer	0.000313	0.00774	CbGeAlD
Doxorubicin—NDUFS2—lymph node—salivary gland cancer	0.000309	0.00765	CbGeAlD
Doxorubicin—CYP1B1—connective tissue—salivary gland cancer	0.000306	0.00757	CbGeAlD
Doxorubicin—NDUFS3—lymph node—salivary gland cancer	0.000306	0.00755	CbGeAlD
Doxorubicin—DHCR7—lymph node—salivary gland cancer	0.00029	0.00718	CbGeAlD
Doxorubicin—ABCC10—lymphoid tissue—salivary gland cancer	0.000285	0.00704	CbGeAlD
Doxorubicin—YWHAG—lymph node—salivary gland cancer	0.000266	0.00659	CbGeAlD
Doxorubicin—ABCG2—parotid gland—salivary gland cancer	0.000259	0.00641	CbGeAlD
Doxorubicin—ABCG2—saliva-secreting gland—salivary gland cancer	0.000248	0.00614	CbGeAlD
Doxorubicin—RALBP1—lymph node—salivary gland cancer	0.000241	0.00595	CbGeAlD
Doxorubicin—NOS3—lymph node—salivary gland cancer	0.000237	0.00585	CbGeAlD
Doxorubicin—CBR1—lymph node—salivary gland cancer	0.000225	0.00555	CbGeAlD
Doxorubicin—CYP1B1—lymphoid tissue—salivary gland cancer	0.000224	0.00554	CbGeAlD
Doxorubicin—AKR1C3—lymph node—salivary gland cancer	0.000222	0.00548	CbGeAlD
Doxorubicin—POR—lymph node—salivary gland cancer	0.000203	0.00501	CbGeAlD
Doxorubicin—TOP2A—lymph node—salivary gland cancer	0.000189	0.00467	CbGeAlD
Doxorubicin—NQO1—lymph node—salivary gland cancer	0.00018	0.00445	CbGeAlD
Doxorubicin—ABCC3—lymph node—salivary gland cancer	0.000162	0.00399	CbGeAlD
Doxorubicin—ABCC10—lymph node—salivary gland cancer	0.000161	0.00397	CbGeAlD
Doxorubicin—CYP2B6—lymphoid tissue—salivary gland cancer	0.000154	0.0038	CbGeAlD
Doxorubicin—ABCC2—lymph node—salivary gland cancer	0.000129	0.00319	CbGeAlD
Doxorubicin—CYP1B1—lymph node—salivary gland cancer	0.000126	0.00312	CbGeAlD
Doxorubicin—ABCC1—lymph node—salivary gland cancer	0.000114	0.00281	CbGeAlD
Doxorubicin—ABCB1—epithelium—salivary gland cancer	0.000107	0.00264	CbGeAlD
Doxorubicin—ABCG2—lymph node—salivary gland cancer	9.41e-05	0.00233	CbGeAlD
Doxorubicin—ABCB1—lymphoid tissue—salivary gland cancer	8.22e-05	0.00203	CbGeAlD
Doxorubicin—ABCB1—lymph node—salivary gland cancer	4.64e-05	0.00115	CbGeAlD
Doxorubicin—NOS1—Disease—NOTCH1—salivary gland cancer	1.42e-05	0.000309	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—EP300—salivary gland cancer	1.41e-05	0.000306	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—salivary gland cancer	1.4e-05	0.000304	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PHGDH—salivary gland cancer	1.39e-05	0.000301	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ST3GAL4—salivary gland cancer	1.38e-05	0.000299	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CCND1—salivary gland cancer	1.37e-05	0.000297	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—EP300—salivary gland cancer	1.37e-05	0.000297	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—PIK3CA—salivary gland cancer	1.34e-05	0.000291	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ST3GAL4—salivary gland cancer	1.33e-05	0.00029	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CREBBP—salivary gland cancer	1.33e-05	0.000288	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—NUP62—salivary gland cancer	1.32e-05	0.000287	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—VCAN—salivary gland cancer	1.31e-05	0.000285	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MAP2K2—salivary gland cancer	1.31e-05	0.000284	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—salivary gland cancer	1.3e-05	0.000282	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CREBBP—salivary gland cancer	1.29e-05	0.00028	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	1.27e-05	0.000276	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PTEN—salivary gland cancer	1.27e-05	0.000276	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PTEN—salivary gland cancer	1.27e-05	0.000276	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NUP62—salivary gland cancer	1.27e-05	0.000275	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—EP300—salivary gland cancer	1.26e-05	0.000274	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PHGDH—salivary gland cancer	1.26e-05	0.000274	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—VCAN—salivary gland cancer	1.26e-05	0.000273	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AQP1—salivary gland cancer	1.25e-05	0.000272	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—JAG1—salivary gland cancer	1.25e-05	0.000271	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NOTCH1—salivary gland cancer	1.24e-05	0.00027	CbGpPWpGaD
Doxorubicin—NOS3—Disease—FOXO3—salivary gland cancer	1.24e-05	0.00027	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FGFR4—salivary gland cancer	1.24e-05	0.00027	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—HRAS—salivary gland cancer	1.24e-05	0.000269	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGF16—salivary gland cancer	1.24e-05	0.000269	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAML2—salivary gland cancer	1.23e-05	0.000268	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FBXW7—salivary gland cancer	1.22e-05	0.000265	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MARCKS—salivary gland cancer	1.22e-05	0.000265	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ST3GAL4—salivary gland cancer	1.21e-05	0.000263	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—EP300—salivary gland cancer	1.21e-05	0.000263	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—EP300—salivary gland cancer	1.21e-05	0.000263	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AQP1—salivary gland cancer	1.21e-05	0.000263	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MAP2K2—salivary gland cancer	1.2e-05	0.000261	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	1.2e-05	0.00026	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PTEN—salivary gland cancer	1.2e-05	0.00026	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—salivary gland cancer	1.19e-05	0.000259	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NUP62—salivary gland cancer	1.19e-05	0.000257	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—VCAN—salivary gland cancer	1.18e-05	0.000255	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.15e-05	0.00025	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	1.14e-05	0.000248	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—EP300—salivary gland cancer	1.14e-05	0.000248	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PYGB—salivary gland cancer	1.13e-05	0.000246	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	1.13e-05	0.000246	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CREBBP—salivary gland cancer	1.13e-05	0.000245	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.1e-05	0.00024	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ISYNA1—salivary gland cancer	1.1e-05	0.00024	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AQP1—salivary gland cancer	1.1e-05	0.000239	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAML2—salivary gland cancer	1.07e-05	0.000233	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NOTCH1—salivary gland cancer	1.07e-05	0.000233	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CCND1—salivary gland cancer	1.07e-05	0.000233	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—EP300—salivary gland cancer	1.06e-05	0.00023	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—JAG1—salivary gland cancer	1.05e-05	0.000229	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FGFR4—salivary gland cancer	1.05e-05	0.000228	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.05e-05	0.000228	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	1.04e-05	0.000226	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FBXW7—salivary gland cancer	1.03e-05	0.000224	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FOXO3—salivary gland cancer	1.03e-05	0.000224	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PTEN—salivary gland cancer	1.02e-05	0.000221	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MAP2K2—salivary gland cancer	1.02e-05	0.000221	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—PIK3CA—salivary gland cancer	1.01e-05	0.00022	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	1.01e-05	0.000219	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NUP62—salivary gland cancer	9.93e-06	0.000216	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—EP300—salivary gland cancer	9.86e-06	0.000214	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—VCAN—salivary gland cancer	9.85e-06	0.000214	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	9.85e-06	0.000214	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NOTCH1—salivary gland cancer	9.85e-06	0.000214	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—salivary gland cancer	9.78e-06	0.000212	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CREBBP—salivary gland cancer	9.71e-06	0.000211	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—EP300—salivary gland cancer	9.69e-06	0.000211	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NUP62—salivary gland cancer	9.6e-06	0.000209	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CCND1—salivary gland cancer	9.58e-06	0.000208	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—VCAN—salivary gland cancer	9.53e-06	0.000207	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTEN—salivary gland cancer	9.48e-06	0.000206	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—HRAS—salivary gland cancer	9.35e-06	0.000203	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PHGDH—salivary gland cancer	9.24e-06	0.000201	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTEN—salivary gland cancer	9.2e-06	0.0002	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—JAG1—salivary gland cancer	9.17e-06	0.000199	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGFR4—salivary gland cancer	9.13e-06	0.000198	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—EP300—salivary gland cancer	9.04e-06	0.000196	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—salivary gland cancer	9.02e-06	0.000196	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MARCKS—salivary gland cancer	8.99e-06	0.000195	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FBXW7—salivary gland cancer	8.98e-06	0.000195	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PIK3CA—salivary gland cancer	8.97e-06	0.000195	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PIK3CA—salivary gland cancer	8.97e-06	0.000195	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CREBBP—salivary gland cancer	8.93e-06	0.000194	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ST3GAL4—salivary gland cancer	8.89e-06	0.000193	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—EP300—salivary gland cancer	8.82e-06	0.000191	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EP300—salivary gland cancer	8.77e-06	0.000191	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NUP62—salivary gland cancer	8.73e-06	0.00019	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FOXO3—salivary gland cancer	8.71e-06	0.000189	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—VCAN—salivary gland cancer	8.67e-06	0.000188	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	8.64e-06	0.000188	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MARCKS—salivary gland cancer	8.47e-06	0.000184	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	8.46e-06	0.000184	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PIK3CA—salivary gland cancer	8.43e-06	0.000183	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAP2K2—salivary gland cancer	8.42e-06	0.000183	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	8.36e-06	0.000182	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PYGB—salivary gland cancer	8.36e-06	0.000182	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCND1—salivary gland cancer	8.35e-06	0.000181	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NOTCH1—salivary gland cancer	8.32e-06	0.000181	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	8.32e-06	0.000181	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	8.22e-06	0.000178	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	8.22e-06	0.000178	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AQP1—salivary gland cancer	8.07e-06	0.000175	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PTEN—salivary gland cancer	8.06e-06	0.000175	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	7.88e-06	0.000171	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PYGB—salivary gland cancer	7.88e-06	0.000171	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—PIK3CA—salivary gland cancer	7.85e-06	0.00017	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	7.84e-06	0.00017	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CREBBP—salivary gland cancer	7.75e-06	0.000168	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EP300—salivary gland cancer	7.68e-06	0.000167	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—salivary gland cancer	7.59e-06	0.000165	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FOXO3—salivary gland cancer	7.58e-06	0.000165	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CREBBP—salivary gland cancer	7.54e-06	0.000164	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	7.51e-06	0.000163	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CREBBP—salivary gland cancer	7.48e-06	0.000162	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	7.29e-06	0.000158	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—HRAS—salivary gland cancer	7.26e-06	0.000158	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	7.23e-06	0.000157	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PIK3CA—salivary gland cancer	7.17e-06	0.000156	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAP2K2—salivary gland cancer	7.11e-06	0.000154	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	7.03e-06	0.000153	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CREBBP—salivary gland cancer	6.95e-06	0.000151	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTEN—salivary gland cancer	6.94e-06	0.000151	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOTCH1—salivary gland cancer	6.89e-06	0.00015	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PHGDH—salivary gland cancer	6.81e-06	0.000148	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	6.79e-06	0.000148	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	6.71e-06	0.000146	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PIK3CA—salivary gland cancer	6.69e-06	0.000145	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EP300—salivary gland cancer	6.62e-06	0.000144	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	6.56e-06	0.000142	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PIK3CA—salivary gland cancer	6.49e-06	0.000141	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PHGDH—salivary gland cancer	6.42e-06	0.000139	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NUP62—salivary gland cancer	6.4e-06	0.000139	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTEN—salivary gland cancer	6.38e-06	0.000138	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—VCAN—salivary gland cancer	6.35e-06	0.000138	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CREBBP—salivary gland cancer	6.32e-06	0.000137	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—salivary gland cancer	6.31e-06	0.000137	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CREBBP—salivary gland cancer	6.25e-06	0.000136	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAP2K2—salivary gland cancer	6.19e-06	0.000134	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	6.18e-06	0.000134	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	6.17e-06	0.000134	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EP300—salivary gland cancer	6.08e-06	0.000132	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HRAS—salivary gland cancer	6e-06	0.00013	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	5.97e-06	0.00013	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AQP1—salivary gland cancer	5.96e-06	0.000129	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	5.89e-06	0.000128	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NOTCH1—salivary gland cancer	5.83e-06	0.000127	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.8e-06	0.000126	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	5.69e-06	0.000124	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PIK3CA—salivary gland cancer	5.68e-06	0.000123	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AQP1—salivary gland cancer	5.61e-06	0.000122	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.56e-06	0.000121	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MARCKS—salivary gland cancer	5.54e-06	0.00012	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTEN—salivary gland cancer	5.53e-06	0.00012	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—salivary gland cancer	5.5e-06	0.000119	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTEN—salivary gland cancer	5.39e-06	0.000117	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTEN—salivary gland cancer	5.34e-06	0.000116	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CREBBP—salivary gland cancer	5.28e-06	0.000115	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—EP300—salivary gland cancer	5.28e-06	0.000115	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HRAS—salivary gland cancer	5.26e-06	0.000114	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PYGB—salivary gland cancer	5.15e-06	0.000112	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EP300—salivary gland cancer	5.14e-06	0.000112	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CREBBP—salivary gland cancer	5.12e-06	0.000111	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—EP300—salivary gland cancer	5.09e-06	0.000111	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOTCH1—salivary gland cancer	5.07e-06	0.00011	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTEN—salivary gland cancer	4.96e-06	0.000108	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	4.96e-06	0.000108	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CREBBP—salivary gland cancer	4.91e-06	0.000107	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PIK3CA—salivary gland cancer	4.89e-06	0.000106	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	4.8e-06	0.000104	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—EP300—salivary gland cancer	4.73e-06	0.000103	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NUP62—salivary gland cancer	4.72e-06	0.000103	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—VCAN—salivary gland cancer	4.69e-06	0.000102	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCND1—salivary gland cancer	4.63e-06	0.0001	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CREBBP—salivary gland cancer	4.6e-06	9.98e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HRAS—salivary gland cancer	4.53e-06	9.83e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTEN—salivary gland cancer	4.51e-06	9.8e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PIK3CA—salivary gland cancer	4.5e-06	9.77e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTEN—salivary gland cancer	4.46e-06	9.7e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NUP62—salivary gland cancer	4.45e-06	9.67e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—VCAN—salivary gland cancer	4.42e-06	9.59e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	4.35e-06	9.46e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—EP300—salivary gland cancer	4.3e-06	9.34e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EP300—salivary gland cancer	4.26e-06	9.25e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	4.21e-06	9.15e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PHGDH—salivary gland cancer	4.2e-06	9.12e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HRAS—salivary gland cancer	4.16e-06	9.04e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	4.04e-06	8.78e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	3.91e-06	8.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCND1—salivary gland cancer	3.91e-06	8.49e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PIK3CA—salivary gland cancer	3.9e-06	8.48e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CREBBP—salivary gland cancer	3.85e-06	8.36e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PIK3CA—salivary gland cancer	3.8e-06	8.25e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTEN—salivary gland cancer	3.77e-06	8.19e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PIK3CA—salivary gland cancer	3.77e-06	8.18e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CREBBP—salivary gland cancer	3.72e-06	8.09e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AQP1—salivary gland cancer	3.67e-06	7.97e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTEN—salivary gland cancer	3.66e-06	7.95e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EP300—salivary gland cancer	3.6e-06	7.81e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—salivary gland cancer	3.52e-06	7.64e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTEN—salivary gland cancer	3.51e-06	7.62e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PIK3CA—salivary gland cancer	3.5e-06	7.61e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—EP300—salivary gland cancer	3.49e-06	7.58e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CREBBP—salivary gland cancer	3.39e-06	7.36e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—EP300—salivary gland cancer	3.35e-06	7.27e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTEN—salivary gland cancer	3.28e-06	7.13e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PIK3CA—salivary gland cancer	3.18e-06	6.91e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PIK3CA—salivary gland cancer	3.15e-06	6.84e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EP300—salivary gland cancer	3.13e-06	6.8e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—salivary gland cancer	3.05e-06	6.62e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—salivary gland cancer	2.91e-06	6.33e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NUP62—salivary gland cancer	2.91e-06	6.32e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—VCAN—salivary gland cancer	2.89e-06	6.27e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTEN—salivary gland cancer	2.75e-06	5.97e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CA—salivary gland cancer	2.66e-06	5.78e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTEN—salivary gland cancer	2.66e-06	5.77e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—EP300—salivary gland cancer	2.62e-06	5.69e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CA—salivary gland cancer	2.58e-06	5.61e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—salivary gland cancer	2.57e-06	5.59e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—EP300—salivary gland cancer	2.54e-06	5.51e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CREBBP—salivary gland cancer	2.48e-06	5.39e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CA—salivary gland cancer	2.47e-06	5.38e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—salivary gland cancer	2.46e-06	5.35e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTEN—salivary gland cancer	2.42e-06	5.25e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CA—salivary gland cancer	2.32e-06	5.03e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—EP300—salivary gland cancer	2.31e-06	5.01e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—salivary gland cancer	2.14e-06	4.65e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CA—salivary gland cancer	1.94e-06	4.21e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CA—salivary gland cancer	1.88e-06	4.07e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CREBBP—salivary gland cancer	1.83e-06	3.98e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTEN—salivary gland cancer	1.77e-06	3.85e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CREBBP—salivary gland cancer	1.73e-06	3.75e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CA—salivary gland cancer	1.71e-06	3.71e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—EP300—salivary gland cancer	1.69e-06	3.67e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTEN—salivary gland cancer	1.31e-06	2.84e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CA—salivary gland cancer	1.25e-06	2.72e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—EP300—salivary gland cancer	1.25e-06	2.71e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTEN—salivary gland cancer	1.23e-06	2.68e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—EP300—salivary gland cancer	1.18e-06	2.55e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CREBBP—salivary gland cancer	1.13e-06	2.45e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CA—salivary gland cancer	9.23e-07	2e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	8.69e-07	1.89e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTEN—salivary gland cancer	8.06e-07	1.75e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—EP300—salivary gland cancer	7.68e-07	1.67e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	5.68e-07	1.23e-05	CbGpPWpGaD
